Anna Muchnik
Papers
1
Total Citations
35
H-Index
1
About
Dr. Anna Muchnik is a pioneering surgical oncologist whose research centers on intraoperative molecular imaging and fluorescence-guided surgery for prostate cancer. Her landmark first-in-human study, published in 2023 with 35 citations, evaluated IS-002—a novel near-infrared fluorescent small molecule targeting prostate-specific membrane antigen (PSMA)—in patients with high-risk prostate cancer undergoing robotic-assisted prostatectomy. This groundbreaking work demonstrated the safety, pharmacokinetics, and exploratory efficacy of real-time fluorescence-based identification of malignant tissue, addressing the critical challenge of incomplete tumor resection that often leads to disease recurrence. Dr. Muchnik's contributions bridge the gap between molecular imaging and surgical precision, offering a transformative approach to visualizing microscopic disease extensions that evade conventional techniques. Her research has profound implications for reducing positive surgical margins and improving oncologic outcomes in high-risk patients. By pioneering the clinical translation of PSMA-targeted fluorophores, she has established a new paradigm for intraoperative decision-making, positioning herself at the forefront of precision oncologic surgery. Her work continues to shape the future of image-guided interventions in urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1